Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia 9Breast Neoplasms 4Wilms Tumor 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Head and Neck Neoplasms 2Congenital Abnormalities 2Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Leydig Cell Tumor 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Immunoenzyme Techniques 3Docetaxel 3N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Immunohistochemistry 2AEG 35156 2temsirolimus 1sabarubicin 1halofuginone 1Trabectedin 1SB939 compound 1Reverse Transcriptase Polymerase Chain Reaction 1N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine 1Mass Spectrometry 1Immunologic Techniques 1Flow Cytometry 1Fenretinide 1Chromatography, Liquid 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Unspecified Adult Solid Tumor, Protocol Specific × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00372736 2023-08-04

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
27 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡